捷强装备内控缺陷四高管被警示 上市累亏2.56亿股价年内仍涨70%

Core Viewpoint - The company Jieqiang Equipment (300875.SZ) faces significant operational challenges and regulatory scrutiny despite its stock price performing well in the market. The company has been ordered to rectify internal control deficiencies and has experienced ongoing financial losses since its IPO in 2020 [2][3][4]. Regulatory Issues - Jieqiang Equipment received an administrative regulatory decision from the Tianjin Securities Regulatory Bureau due to internal control deficiencies, leading to warnings issued to four senior executives, including the chairman and general manager [2][5][6]. - The company has been found to have significant issues in financial and contract management, including improper use of employee personal bank accounts for transactions and signing of fictitious contracts [5][6]. Financial Performance - The company reported a loss of 0.23 billion yuan in the first three quarters of 2025, with cumulative losses of 3.86 billion yuan since 2022 [3][14]. - Since its IPO, Jieqiang Equipment has accumulated a net profit loss of 2.56 billion yuan, with a notable decline in profitability since 2021 [4][14]. Stock Market Performance - Despite the financial struggles, Jieqiang Equipment's stock has seen a significant increase, rising over 70% since the beginning of 2025, with a remarkable 2.2 times increase in stock price from April 9 to August 8 [4][15]. Company Background - Established in November 2005, Jieqiang Equipment focuses on the research, production, and sales of nuclear and biochemical safety equipment, aiming to provide integrated solutions in public safety and environmental protection [11].